BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 12121933)

  • 1. Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis.
    Kirkpatrick WR; Perea S; Coco BJ; Patterson TF
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2564-8. PubMed ID: 12121933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis.
    Kirkpatrick WR; McAtee RK; Fothergill AW; Rinaldi MG; Patterson TF
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2865-8. PubMed ID: 10991875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.
    Clemons KV; Espiritu M; Parmar R; Stevens DA
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4867-75. PubMed ID: 16304147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of the combination of voriconazole and caspofungin in experimental pulmonary aspergillosis by different Aspergillus species.
    Zhang M; Su X; Sun WK; Chen F; Xu XY; Shi Y
    Mycopathologia; 2014 Feb; 177(1-2):11-8. PubMed ID: 24306184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
    Chandrasekar PH; Cutright JL; Manavathu EK
    Clin Microbiol Infect; 2004 Oct; 10(10):925-8. PubMed ID: 15373889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis.
    MacCallum DM; Whyte JA; Odds FC
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3697-701. PubMed ID: 16127042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential or combination antifungal therapy with voriconazole and liposomal amphotericin B in a Guinea pig model of invasive aspergillosis.
    Kirkpatrick WR; Coco BJ; Patterson TF
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1567-9. PubMed ID: 16569887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis.
    Clemons KV; Schwartz JA; Stevens DA
    Med Mycol; 2011 Nov; 49(8):834-47. PubMed ID: 21539507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspofungin: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosis.
    van Vianen W; de Marie S; ten Kate MT; Mathot RA; Bakker-Woudenberg IA
    J Antimicrob Chemother; 2006 Apr; 57(4):732-40. PubMed ID: 16464895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Abelcet and caspofungin, alone or in combination, against CNS aspergillosis in a murine model.
    Imai J; Singh G; Fernandez B; Clemons KV; Stevens DA
    J Antimicrob Chemother; 2005 Jul; 56(1):166-71. PubMed ID: 15917284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.
    Singh N; Limaye AP; Forrest G; Safdar N; Muñoz P; Pursell K; Houston S; Rosso F; Montoya JG; Patton P; Del Busto R; Aguado JM; Fisher RA; Klintmalm GB; Miller R; Wagener MM; Lewis RE; Kontoyiannis DP; Husain S
    Transplantation; 2006 Feb; 81(3):320-6. PubMed ID: 16477215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
    Sims-McCallum RP
    Am J Health Syst Pharm; 2003 Nov; 60(22):2352-6. PubMed ID: 14652986
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus.
    Warn PA; Sharp A; Mosquera J; Spickermann J; Schmitt-Hoffmann A; Heep M; Denning DW
    J Antimicrob Chemother; 2006 Dec; 58(6):1198-207. PubMed ID: 17071636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
    Raad II; Hanna HA; Boktour M; Jiang Y; Torres HA; Afif C; Kontoyiannis DP; Hachem RY
    Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia.
    Petraitiene R; Petraitis V; Groll AH; Sein T; Schaufele RL; Francesconi A; Bacher J; Avila NA; Walsh TJ
    Antimicrob Agents Chemother; 2002 Jan; 46(1):12-23. PubMed ID: 11751105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination antifungal therapy for invasive aspergillosis.
    Marr KA; Boeckh M; Carter RA; Kim HW; Corey L
    Clin Infect Dis; 2004 Sep; 39(6):797-802. PubMed ID: 15472810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach.
    Ament AJ; Hübben MW; Verweij PE; de Groot R; Warris A; Donnelly JP; van 't Wout J; Severens JL
    J Antimicrob Chemother; 2007 Aug; 60(2):385-93. PubMed ID: 17561501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comment: caspofungin acetate for treatment of invasive fungal infections.
    Chan J
    Ann Pharmacother; 2003 Apr; 37(4):595. PubMed ID: 12659624
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig model.
    Chandrasekar PH; Cutright J; Manavathu E
    J Antimicrob Chemother; 2000 May; 45(5):673-6. PubMed ID: 10797091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole.
    Forestier E; Remy V; Lesens O; Martinot M; Hansman Y; Eisenmann B; Christmann D
    Eur J Clin Microbiol Infect Dis; 2005 May; 24(5):347-9. PubMed ID: 15889298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.